291
Views
1
CrossRef citations to date
0
Altmetric
Reports

Red light emitting diode as an adjuvant treatment for epidermal growth factor receptor inhibitors-induced paronychia

, , , , , & show all
Pages 1990-1994 | Received 15 Feb 2021, Accepted 30 Apr 2021, Published online: 24 May 2021
 

Abstract

We evaluated the efficacy and safety of red light LED as an adjuvant treatment for epidermal growth factor receptor inhibitor-induced paronychia. Eight patients were recruited in this randomized, single-blinded controlled trial. They were randomized to receive red-light on one hand or foot 2–3 times/week for 6 weeks while the contralateral side served as controls. The standard treatments were continued. Erythema and lesion elevation observed by Anthera® 3D, severity and pain scores were obtained at weeks 0, 2, 4, 6, and 8. The red light group showed significantly lower erythema, severity, and pain scores at weeks 4, 6, and 8. The elevation was significantly lower in the red light group at every follow-up visit. No adverse events occurred. Red light therapy may be an option as adjunctive treatment for EGFRi-induced paronychia.

Acknowledgements

The study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the Institutional Review Board of Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB no. 176/62). The trial was registered with Thai Clinical Trials Registry, number TCTR20200413002. Written informed consent was obtained from each participant prior to enrollment. The authors thank the Skin and Allergy Research Unit, Chulalongkorn University for their support.

Disclosure statement

Authors declare no conflicts of interest for this article.

Additional information

Funding

This work is supported by Ratchadapisek Somphot Endowment Fund, RA61/079, Faculty of Medicine, Chulalongkorn University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.